0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meloxicam Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-5C7907
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Meloxicam Market Insights and Forecast to 2028
BUY CHAPTERS

Global Meloxicam Market Research Report 2025

Code: QYRE-Auto-5C7907
Report
July 2025
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Meloxicam Market

The global market for Meloxicam was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Meloxicam is an enol nonsteroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects.Selective inhibition of cox-2 (cox-2), the inhibition of cox-1 is weak, so the digestive system and other adverse reactions are less.
North American market for Meloxicam is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Meloxicam is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Meloxicam include Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences, Cellix Bio, Ligand Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meloxicam, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meloxicam.
The Meloxicam market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meloxicam market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meloxicam manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meloxicam Market Report

Report Metric Details
Report Name Meloxicam Market
Segment by Type
  • by Ingredient
  • by Route
  • by Dosage Form
Segment by Application
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Soft Tissue Inflammation
  • Traumatic Pain
  • Post-Operative Pain
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences, Cellix Bio, Ligand Pharma, SEDOR Pharma, Heron Therapeutics, Pacira BioSciences, Sanofi, Eurofarma Laboratorio, TerSera Therapeutics, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Zydus Pharmaceuticals, Unichem Pharmaceuticals, Strides Pharma, Cipla, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, PuraCap Pharmaceutical, TARO, Lupin Pharmaceuticals, Aurobindo Pharma, Shanghai Bolinger Ingelheim Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Sichuan Shenghe Pharmaceutical, Ningxia Kangya Pharmaceutical, Yangtze Pharmaceutical Group, Kunshan Longdeng Ruidi Pharmaceutical, Jiangsu Yabang Epson Pharmaceutical, Jiangsu Feima Pharmaceutical Co. , Ltd, Zhejiang Xianju Pharmaceutical, Hainan All Star Pharmaceutical, Hainan Aomeihua Pharmaceutical, Hunan Mingrui Pharmaceutical, Suzhou Sinochem Pharmaceutical, Qilu Pharmaceutical, Sichuan Luye Pharmaceutical, Shandong Xinhua Pharmaceutical, Guangdong Renkang Pharmaceutical, Hainan Selike Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meloxicam manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meloxicam in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meloxicam Market report?

Ans: The main players in the Meloxicam Market are Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences, Cellix Bio, Ligand Pharma, SEDOR Pharma, Heron Therapeutics, Pacira BioSciences, Sanofi, Eurofarma Laboratorio, TerSera Therapeutics, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Zydus Pharmaceuticals, Unichem Pharmaceuticals, Strides Pharma, Cipla, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, PuraCap Pharmaceutical, TARO, Lupin Pharmaceuticals, Aurobindo Pharma, Shanghai Bolinger Ingelheim Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Sichuan Shenghe Pharmaceutical, Ningxia Kangya Pharmaceutical, Yangtze Pharmaceutical Group, Kunshan Longdeng Ruidi Pharmaceutical, Jiangsu Yabang Epson Pharmaceutical, Jiangsu Feima Pharmaceutical Co. , Ltd, Zhejiang Xianju Pharmaceutical, Hainan All Star Pharmaceutical, Hainan Aomeihua Pharmaceutical, Hunan Mingrui Pharmaceutical, Suzhou Sinochem Pharmaceutical, Qilu Pharmaceutical, Sichuan Luye Pharmaceutical, Shandong Xinhua Pharmaceutical, Guangdong Renkang Pharmaceutical, Hainan Selike Pharmaceutical

What are the Application segmentation covered in the Meloxicam Market report?

Ans: The Applications covered in the Meloxicam Market report are Rheumatoid Arthritis, Osteoarthritis, Soft Tissue Inflammation, Traumatic Pain, Post-Operative Pain, Other

What are the Type segmentation covered in the Meloxicam Market report?

Ans: The Types covered in the Meloxicam Market report are by Ingredient, by Route, by Dosage Form

1 Meloxicam Market Overview
1.1 Product Definition
1.2 Meloxicam by Type
1.2.1 Global Meloxicam Market Value Comparison by Type (2024 VS 2031)
1.2.2 by Ingredient
1.2.3 by Route
1.2.4 by Dosage Form
1.3 Meloxicam by Application
1.3.1 Global Meloxicam Market Value by Application (2024 VS 2031)
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Soft Tissue Inflammation
1.3.5 Traumatic Pain
1.3.6 Post-Operative Pain
1.3.7 Other
1.4 Global Meloxicam Market Size Estimates and Forecasts
1.4.1 Global Meloxicam Revenue 2020-2031
1.4.2 Global Meloxicam Sales 2020-2031
1.4.3 Global Meloxicam Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meloxicam Market Competition by Manufacturers
2.1 Global Meloxicam Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meloxicam Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meloxicam Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meloxicam, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meloxicam, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meloxicam, Product Type & Application
2.7 Global Key Manufacturers of Meloxicam, Date of Enter into This Industry
2.8 Global Meloxicam Market Competitive Situation and Trends
2.8.1 Global Meloxicam Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meloxicam Players Market Share by Revenue
2.8.3 Global Meloxicam Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meloxicam Market Scenario by Region
3.1 Global Meloxicam Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meloxicam Sales by Region: 2020-2031
3.2.1 Global Meloxicam Sales by Region: 2020-2025
3.2.2 Global Meloxicam Sales by Region: 2026-2031
3.3 Global Meloxicam Revenue by Region: 2020-2031
3.3.1 Global Meloxicam Revenue by Region: 2020-2025
3.3.2 Global Meloxicam Revenue by Region: 2026-2031
3.4 North America Meloxicam Market Facts & Figures by Country
3.4.1 North America Meloxicam Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meloxicam Sales by Country (2020-2031)
3.4.3 North America Meloxicam Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meloxicam Market Facts & Figures by Country
3.5.1 Europe Meloxicam Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meloxicam Sales by Country (2020-2031)
3.5.3 Europe Meloxicam Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meloxicam Market Facts & Figures by Region
3.6.1 Asia Pacific Meloxicam Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meloxicam Sales by Region (2020-2031)
3.6.3 Asia Pacific Meloxicam Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meloxicam Market Facts & Figures by Country
3.7.1 Latin America Meloxicam Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meloxicam Sales by Country (2020-2031)
3.7.3 Latin America Meloxicam Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meloxicam Market Facts & Figures by Country
3.8.1 Middle East and Africa Meloxicam Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meloxicam Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meloxicam Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meloxicam Sales by Type (2020-2031)
4.1.1 Global Meloxicam Sales by Type (2020-2025)
4.1.2 Global Meloxicam Sales by Type (2026-2031)
4.1.3 Global Meloxicam Sales Market Share by Type (2020-2031)
4.2 Global Meloxicam Revenue by Type (2020-2031)
4.2.1 Global Meloxicam Revenue by Type (2020-2025)
4.2.2 Global Meloxicam Revenue by Type (2026-2031)
4.2.3 Global Meloxicam Revenue Market Share by Type (2020-2031)
4.3 Global Meloxicam Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meloxicam Sales by Application (2020-2031)
5.1.1 Global Meloxicam Sales by Application (2020-2025)
5.1.2 Global Meloxicam Sales by Application (2026-2031)
5.1.3 Global Meloxicam Sales Market Share by Application (2020-2031)
5.2 Global Meloxicam Revenue by Application (2020-2031)
5.2.1 Global Meloxicam Revenue by Application (2020-2025)
5.2.2 Global Meloxicam Revenue by Application (2026-2031)
5.2.3 Global Meloxicam Revenue Market Share by Application (2020-2031)
5.3 Global Meloxicam Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Meloxicam Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Baudax
6.2.1 Baudax Company Information
6.2.2 Baudax Description and Business Overview
6.2.3 Baudax Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baudax Meloxicam Product Portfolio
6.2.5 Baudax Recent Developments/Updates
6.3 Perrigo
6.3.1 Perrigo Company Information
6.3.2 Perrigo Description and Business Overview
6.3.3 Perrigo Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Perrigo Meloxicam Product Portfolio
6.3.5 Perrigo Recent Developments/Updates
6.4 Recro Pharma
6.4.1 Recro Pharma Company Information
6.4.2 Recro Pharma Description and Business Overview
6.4.3 Recro Pharma Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Recro Pharma Meloxicam Product Portfolio
6.4.5 Recro Pharma Recent Developments/Updates
6.5 Iroko Pharma
6.5.1 Iroko Pharma Company Information
6.5.2 Iroko Pharma Description and Business Overview
6.5.3 Iroko Pharma Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Iroko Pharma Meloxicam Product Portfolio
6.5.5 Iroko Pharma Recent Developments/Updates
6.6 Zyla Life Sciences
6.6.1 Zyla Life Sciences Company Information
6.6.2 Zyla Life Sciences Description and Business Overview
6.6.3 Zyla Life Sciences Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zyla Life Sciences Meloxicam Product Portfolio
6.6.5 Zyla Life Sciences Recent Developments/Updates
6.7 Axsome Therapeutics
6.7.1 Axsome Therapeutics Company Information
6.7.2 Axsome Therapeutics Description and Business Overview
6.7.3 Axsome Therapeutics Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Axsome Therapeutics Meloxicam Product Portfolio
6.7.5 Axsome Therapeutics Recent Developments/Updates
6.8 Orbis Biosciences
6.8.1 Orbis Biosciences Company Information
6.8.2 Orbis Biosciences Description and Business Overview
6.8.3 Orbis Biosciences Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Orbis Biosciences Meloxicam Product Portfolio
6.8.5 Orbis Biosciences Recent Developments/Updates
6.9 Cellix Bio
6.9.1 Cellix Bio Company Information
6.9.2 Cellix Bio Description and Business Overview
6.9.3 Cellix Bio Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cellix Bio Meloxicam Product Portfolio
6.9.5 Cellix Bio Recent Developments/Updates
6.10 Ligand Pharma
6.10.1 Ligand Pharma Company Information
6.10.2 Ligand Pharma Description and Business Overview
6.10.3 Ligand Pharma Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ligand Pharma Meloxicam Product Portfolio
6.10.5 Ligand Pharma Recent Developments/Updates
6.11 SEDOR Pharma
6.11.1 SEDOR Pharma Company Information
6.11.2 SEDOR Pharma Description and Business Overview
6.11.3 SEDOR Pharma Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SEDOR Pharma Meloxicam Product Portfolio
6.11.5 SEDOR Pharma Recent Developments/Updates
6.12 Heron Therapeutics
6.12.1 Heron Therapeutics Company Information
6.12.2 Heron Therapeutics Description and Business Overview
6.12.3 Heron Therapeutics Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Heron Therapeutics Meloxicam Product Portfolio
6.12.5 Heron Therapeutics Recent Developments/Updates
6.13 Pacira BioSciences
6.13.1 Pacira BioSciences Company Information
6.13.2 Pacira BioSciences Description and Business Overview
6.13.3 Pacira BioSciences Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pacira BioSciences Meloxicam Product Portfolio
6.13.5 Pacira BioSciences Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Company Information
6.14.2 Sanofi Description and Business Overview
6.14.3 Sanofi Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sanofi Meloxicam Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Eurofarma Laboratorio
6.15.1 Eurofarma Laboratorio Company Information
6.15.2 Eurofarma Laboratorio Description and Business Overview
6.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Eurofarma Laboratorio Meloxicam Product Portfolio
6.15.5 Eurofarma Laboratorio Recent Developments/Updates
6.16 TerSera Therapeutics
6.16.1 TerSera Therapeutics Company Information
6.16.2 TerSera Therapeutics Description and Business Overview
6.16.3 TerSera Therapeutics Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.16.4 TerSera Therapeutics Meloxicam Product Portfolio
6.16.5 TerSera Therapeutics Recent Developments/Updates
6.17 Apotex
6.17.1 Apotex Company Information
6.17.2 Apotex Description and Business Overview
6.17.3 Apotex Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Apotex Meloxicam Product Portfolio
6.17.5 Apotex Recent Developments/Updates
6.18 Yung Shin Pharmaceutical
6.18.1 Yung Shin Pharmaceutical Company Information
6.18.2 Yung Shin Pharmaceutical Description and Business Overview
6.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Yung Shin Pharmaceutical Meloxicam Product Portfolio
6.18.5 Yung Shin Pharmaceutical Recent Developments/Updates
6.19 Breckenridge Pharmaceutical
6.19.1 Breckenridge Pharmaceutical Company Information
6.19.2 Breckenridge Pharmaceutical Description and Business Overview
6.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Breckenridge Pharmaceutical Meloxicam Product Portfolio
6.19.5 Breckenridge Pharmaceutical Recent Developments/Updates
6.20 Zydus Pharmaceuticals
6.20.1 Zydus Pharmaceuticals Company Information
6.20.2 Zydus Pharmaceuticals Description and Business Overview
6.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Zydus Pharmaceuticals Meloxicam Product Portfolio
6.20.5 Zydus Pharmaceuticals Recent Developments/Updates
6.21 Unichem Pharmaceuticals
6.21.1 Unichem Pharmaceuticals Company Information
6.21.2 Unichem Pharmaceuticals Description and Business Overview
6.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Unichem Pharmaceuticals Meloxicam Product Portfolio
6.21.5 Unichem Pharmaceuticals Recent Developments/Updates
6.22 Strides Pharma
6.22.1 Strides Pharma Company Information
6.22.2 Strides Pharma Description and Business Overview
6.22.3 Strides Pharma Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Strides Pharma Meloxicam Product Portfolio
6.22.5 Strides Pharma Recent Developments/Updates
6.23 Cipla
6.23.1 Cipla Company Information
6.23.2 Cipla Description and Business Overview
6.23.3 Cipla Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Cipla Meloxicam Product Portfolio
6.23.5 Cipla Recent Developments/Updates
6.24 Dr. Reddy's Laboratories
6.24.1 Dr. Reddy's Laboratories Company Information
6.24.2 Dr. Reddy's Laboratories Description and Business Overview
6.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Dr. Reddy's Laboratories Meloxicam Product Portfolio
6.24.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.25 Glenmark Pharmaceuticals
6.25.1 Glenmark Pharmaceuticals Company Information
6.25.2 Glenmark Pharmaceuticals Description and Business Overview
6.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Glenmark Pharmaceuticals Meloxicam Product Portfolio
6.25.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.26 Teva
6.26.1 Teva Company Information
6.26.2 Teva Description and Business Overview
6.26.3 Teva Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Teva Meloxicam Product Portfolio
6.26.5 Teva Recent Developments/Updates
6.27 PuraCap Pharmaceutical
6.27.1 PuraCap Pharmaceutical Company Information
6.27.2 PuraCap Pharmaceutical Description and Business Overview
6.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.27.4 PuraCap Pharmaceutical Meloxicam Product Portfolio
6.27.5 PuraCap Pharmaceutical Recent Developments/Updates
6.28 TARO
6.28.1 TARO Company Information
6.28.2 TARO Description and Business Overview
6.28.3 TARO Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.28.4 TARO Meloxicam Product Portfolio
6.28.5 TARO Recent Developments/Updates
6.29 Lupin Pharmaceuticals
6.29.1 Lupin Pharmaceuticals Company Information
6.29.2 Lupin Pharmaceuticals Description and Business Overview
6.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.29.4 Lupin Pharmaceuticals Meloxicam Product Portfolio
6.29.5 Lupin Pharmaceuticals Recent Developments/Updates
6.30 Aurobindo Pharma
6.30.1 Aurobindo Pharma Company Information
6.30.2 Aurobindo Pharma Description and Business Overview
6.30.3 Aurobindo Pharma Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.30.4 Aurobindo Pharma Meloxicam Product Portfolio
6.30.5 Aurobindo Pharma Recent Developments/Updates
6.31 Shanghai Bolinger Ingelheim Pharmaceutical
6.31.1 Shanghai Bolinger Ingelheim Pharmaceutical Company Information
6.31.2 Shanghai Bolinger Ingelheim Pharmaceutical Description and Business Overview
6.31.3 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.31.4 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product Portfolio
6.31.5 Shanghai Bolinger Ingelheim Pharmaceutical Recent Developments/Updates
6.32 Shanghai Zhaohui Pharmaceutical
6.32.1 Shanghai Zhaohui Pharmaceutical Company Information
6.32.2 Shanghai Zhaohui Pharmaceutical Description and Business Overview
6.32.3 Shanghai Zhaohui Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.32.4 Shanghai Zhaohui Pharmaceutical Meloxicam Product Portfolio
6.32.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
6.33 Sichuan Shenghe Pharmaceutical
6.33.1 Sichuan Shenghe Pharmaceutical Company Information
6.33.2 Sichuan Shenghe Pharmaceutical Description and Business Overview
6.33.3 Sichuan Shenghe Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.33.4 Sichuan Shenghe Pharmaceutical Meloxicam Product Portfolio
6.33.5 Sichuan Shenghe Pharmaceutical Recent Developments/Updates
6.34 Ningxia Kangya Pharmaceutical
6.34.1 Ningxia Kangya Pharmaceutical Company Information
6.34.2 Ningxia Kangya Pharmaceutical Description and Business Overview
6.34.3 Ningxia Kangya Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.34.4 Ningxia Kangya Pharmaceutical Meloxicam Product Portfolio
6.34.5 Ningxia Kangya Pharmaceutical Recent Developments/Updates
6.35 Yangtze Pharmaceutical Group
6.35.1 Yangtze Pharmaceutical Group Company Information
6.35.2 Yangtze Pharmaceutical Group Description and Business Overview
6.35.3 Yangtze Pharmaceutical Group Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.35.4 Yangtze Pharmaceutical Group Meloxicam Product Portfolio
6.35.5 Yangtze Pharmaceutical Group Recent Developments/Updates
6.36 Kunshan Longdeng Ruidi Pharmaceutical
6.36.1 Kunshan Longdeng Ruidi Pharmaceutical Company Information
6.36.2 Kunshan Longdeng Ruidi Pharmaceutical Description and Business Overview
6.36.3 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.36.4 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Product Portfolio
6.36.5 Kunshan Longdeng Ruidi Pharmaceutical Recent Developments/Updates
6.37 Jiangsu Yabang Epson Pharmaceutical
6.37.1 Jiangsu Yabang Epson Pharmaceutical Company Information
6.37.2 Jiangsu Yabang Epson Pharmaceutical Description and Business Overview
6.37.3 Jiangsu Yabang Epson Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.37.4 Jiangsu Yabang Epson Pharmaceutical Meloxicam Product Portfolio
6.37.5 Jiangsu Yabang Epson Pharmaceutical Recent Developments/Updates
6.38 Jiangsu Feima Pharmaceutical Co. , Ltd
6.38.1 Jiangsu Feima Pharmaceutical Co. , Ltd Company Information
6.38.2 Jiangsu Feima Pharmaceutical Co. , Ltd Description and Business Overview
6.38.3 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.38.4 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Product Portfolio
6.38.5 Jiangsu Feima Pharmaceutical Co. , Ltd Recent Developments/Updates
6.39 Zhejiang Xianju Pharmaceutical
6.39.1 Zhejiang Xianju Pharmaceutical Company Information
6.39.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.39.3 Zhejiang Xianju Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.39.4 Zhejiang Xianju Pharmaceutical Meloxicam Product Portfolio
6.39.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.40 Hainan All Star Pharmaceutical
6.40.1 Hainan All Star Pharmaceutical Company Information
6.40.2 Hainan All Star Pharmaceutical Description and Business Overview
6.40.3 Hainan All Star Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2020-2025)
6.40.4 Hainan All Star Pharmaceutical Meloxicam Product Portfolio
6.40.5 Hainan All Star Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meloxicam Industry Chain Analysis
7.2 Meloxicam Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meloxicam Production Mode & Process Analysis
7.4 Meloxicam Sales and Marketing
7.4.1 Meloxicam Sales Channels
7.4.2 Meloxicam Distributors
7.5 Meloxicam Customer Analysis
8 Meloxicam Market Dynamics
8.1 Meloxicam Industry Trends
8.2 Meloxicam Market Drivers
8.3 Meloxicam Market Challenges
8.4 Meloxicam Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Meloxicam Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Meloxicam Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Meloxicam Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Meloxicam Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Meloxicam Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Meloxicam Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Meloxicam Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Meloxicam Average Price (US$/G) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Meloxicam, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meloxicam, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meloxicam, Product Type & Application
 Table 12. Global Key Manufacturers of Meloxicam, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meloxicam by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meloxicam as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meloxicam Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Meloxicam Sales by Region (2020-2025) & (KG)
 Table 18. Global Meloxicam Sales Market Share by Region (2020-2025)
 Table 19. Global Meloxicam Sales by Region (2026-2031) & (KG)
 Table 20. Global Meloxicam Sales Market Share by Region (2026-2031)
 Table 21. Global Meloxicam Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Meloxicam Revenue Market Share by Region (2020-2025)
 Table 23. Global Meloxicam Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Meloxicam Revenue Market Share by Region (2026-2031)
 Table 25. North America Meloxicam Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Meloxicam Sales by Country (2020-2025) & (KG)
 Table 27. North America Meloxicam Sales by Country (2026-2031) & (KG)
 Table 28. North America Meloxicam Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Meloxicam Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Meloxicam Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Meloxicam Sales by Country (2020-2025) & (KG)
 Table 32. Europe Meloxicam Sales by Country (2026-2031) & (KG)
 Table 33. Europe Meloxicam Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Meloxicam Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Meloxicam Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Meloxicam Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Meloxicam Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Meloxicam Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Meloxicam Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Meloxicam Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Meloxicam Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Meloxicam Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Meloxicam Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Meloxicam Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Meloxicam Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Meloxicam Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Meloxicam Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Meloxicam Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Meloxicam Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Meloxicam Sales (KG) by Type (2020-2025)
 Table 51. Global Meloxicam Sales (KG) by Type (2026-2031)
 Table 52. Global Meloxicam Sales Market Share by Type (2020-2025)
 Table 53. Global Meloxicam Sales Market Share by Type (2026-2031)
 Table 54. Global Meloxicam Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Meloxicam Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Meloxicam Revenue Market Share by Type (2020-2025)
 Table 57. Global Meloxicam Revenue Market Share by Type (2026-2031)
 Table 58. Global Meloxicam Price (US$/G) by Type (2020-2025)
 Table 59. Global Meloxicam Price (US$/G) by Type (2026-2031)
 Table 60. Global Meloxicam Sales (KG) by Application (2020-2025)
 Table 61. Global Meloxicam Sales (KG) by Application (2026-2031)
 Table 62. Global Meloxicam Sales Market Share by Application (2020-2025)
 Table 63. Global Meloxicam Sales Market Share by Application (2026-2031)
 Table 64. Global Meloxicam Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Meloxicam Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Meloxicam Revenue Market Share by Application (2020-2025)
 Table 67. Global Meloxicam Revenue Market Share by Application (2026-2031)
 Table 68. Global Meloxicam Price (US$/G) by Application (2020-2025)
 Table 69. Global Meloxicam Price (US$/G) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Meloxicam Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Baudax Company Information
 Table 76. Baudax Description and Business Overview
 Table 77. Baudax Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 78. Baudax Meloxicam Product
 Table 79. Baudax Recent Developments/Updates
 Table 80. Perrigo Company Information
 Table 81. Perrigo Description and Business Overview
 Table 82. Perrigo Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 83. Perrigo Meloxicam Product
 Table 84. Perrigo Recent Developments/Updates
 Table 85. Recro Pharma Company Information
 Table 86. Recro Pharma Description and Business Overview
 Table 87. Recro Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 88. Recro Pharma Meloxicam Product
 Table 89. Recro Pharma Recent Developments/Updates
 Table 90. Iroko Pharma Company Information
 Table 91. Iroko Pharma Description and Business Overview
 Table 92. Iroko Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 93. Iroko Pharma Meloxicam Product
 Table 94. Iroko Pharma Recent Developments/Updates
 Table 95. Zyla Life Sciences Company Information
 Table 96. Zyla Life Sciences Description and Business Overview
 Table 97. Zyla Life Sciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 98. Zyla Life Sciences Meloxicam Product
 Table 99. Zyla Life Sciences Recent Developments/Updates
 Table 100. Axsome Therapeutics Company Information
 Table 101. Axsome Therapeutics Description and Business Overview
 Table 102. Axsome Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 103. Axsome Therapeutics Meloxicam Product
 Table 104. Axsome Therapeutics Recent Developments/Updates
 Table 105. Orbis Biosciences Company Information
 Table 106. Orbis Biosciences Description and Business Overview
 Table 107. Orbis Biosciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 108. Orbis Biosciences Meloxicam Product
 Table 109. Orbis Biosciences Recent Developments/Updates
 Table 110. Cellix Bio Company Information
 Table 111. Cellix Bio Description and Business Overview
 Table 112. Cellix Bio Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 113. Cellix Bio Meloxicam Product
 Table 114. Cellix Bio Recent Developments/Updates
 Table 115. Ligand Pharma Company Information
 Table 116. Ligand Pharma Description and Business Overview
 Table 117. Ligand Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 118. Ligand Pharma Meloxicam Product
 Table 119. Ligand Pharma Recent Developments/Updates
 Table 120. SEDOR Pharma Company Information
 Table 121. SEDOR Pharma Description and Business Overview
 Table 122. SEDOR Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 123. SEDOR Pharma Meloxicam Product
 Table 124. SEDOR Pharma Recent Developments/Updates
 Table 125. Heron Therapeutics Company Information
 Table 126. Heron Therapeutics Description and Business Overview
 Table 127. Heron Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 128. Heron Therapeutics Meloxicam Product
 Table 129. Heron Therapeutics Recent Developments/Updates
 Table 130. Pacira BioSciences Company Information
 Table 131. Pacira BioSciences Description and Business Overview
 Table 132. Pacira BioSciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 133. Pacira BioSciences Meloxicam Product
 Table 134. Pacira BioSciences Recent Developments/Updates
 Table 135. Sanofi Company Information
 Table 136. Sanofi Description and Business Overview
 Table 137. Sanofi Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 138. Sanofi Meloxicam Product
 Table 139. Sanofi Recent Developments/Updates
 Table 140. Eurofarma Laboratorio Company Information
 Table 141. Eurofarma Laboratorio Description and Business Overview
 Table 142. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 143. Eurofarma Laboratorio Meloxicam Product
 Table 144. Eurofarma Laboratorio Recent Developments/Updates
 Table 145. TerSera Therapeutics Company Information
 Table 146. TerSera Therapeutics Description and Business Overview
 Table 147. TerSera Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 148. TerSera Therapeutics Meloxicam Product
 Table 149. TerSera Therapeutics Recent Developments/Updates
 Table 150. Apotex Company Information
 Table 151. Apotex Description and Business Overview
 Table 152. Apotex Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 153. Apotex Meloxicam Product
 Table 154. Apotex Recent Developments/Updates
 Table 155. Yung Shin Pharmaceutical Company Information
 Table 156. Yung Shin Pharmaceutical Description and Business Overview
 Table 157. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 158. Yung Shin Pharmaceutical Meloxicam Product
 Table 159. Yung Shin Pharmaceutical Recent Developments/Updates
 Table 160. Breckenridge Pharmaceutical Company Information
 Table 161. Breckenridge Pharmaceutical Description and Business Overview
 Table 162. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 163. Breckenridge Pharmaceutical Meloxicam Product
 Table 164. Breckenridge Pharmaceutical Recent Developments/Updates
 Table 165. Zydus Pharmaceuticals Company Information
 Table 166. Zydus Pharmaceuticals Description and Business Overview
 Table 167. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 168. Zydus Pharmaceuticals Meloxicam Product
 Table 169. Zydus Pharmaceuticals Recent Developments/Updates
 Table 170. Unichem Pharmaceuticals Company Information
 Table 171. Unichem Pharmaceuticals Description and Business Overview
 Table 172. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 173. Unichem Pharmaceuticals Meloxicam Product
 Table 174. Unichem Pharmaceuticals Recent Developments/Updates
 Table 175. Strides Pharma Company Information
 Table 176. Strides Pharma Description and Business Overview
 Table 177. Strides Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 178. Strides Pharma Meloxicam Product
 Table 179. Strides Pharma Recent Developments/Updates
 Table 180. Cipla Company Information
 Table 181. Cipla Description and Business Overview
 Table 182. Cipla Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 183. Cipla Meloxicam Product
 Table 184. Cipla Recent Developments/Updates
 Table 185. Dr. Reddy's Laboratories Company Information
 Table 186. Dr. Reddy's Laboratories Description and Business Overview
 Table 187. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 188. Dr. Reddy's Laboratories Meloxicam Product
 Table 189. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 190. Glenmark Pharmaceuticals Company Information
 Table 191. Glenmark Pharmaceuticals Description and Business Overview
 Table 192. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 193. Glenmark Pharmaceuticals Meloxicam Product
 Table 194. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 195. Teva Company Information
 Table 196. Teva Description and Business Overview
 Table 197. Teva Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 198. Teva Meloxicam Product
 Table 199. Teva Recent Developments/Updates
 Table 200. PuraCap Pharmaceutical Company Information
 Table 201. PuraCap Pharmaceutical Description and Business Overview
 Table 202. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 203. PuraCap Pharmaceutical Meloxicam Product
 Table 204. PuraCap Pharmaceutical Recent Developments/Updates
 Table 205. TARO Company Information
 Table 206. TARO Description and Business Overview
 Table 207. TARO Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 208. TARO Meloxicam Product
 Table 209. TARO Recent Developments/Updates
 Table 210. Lupin Pharmaceuticals Company Information
 Table 211. Lupin Pharmaceuticals Description and Business Overview
 Table 212. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 213. Lupin Pharmaceuticals Meloxicam Product
 Table 214. Lupin Pharmaceuticals Recent Developments/Updates
 Table 215. Aurobindo Pharma Company Information
 Table 216. Aurobindo Pharma Description and Business Overview
 Table 217. Aurobindo Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 218. Aurobindo Pharma Meloxicam Product
 Table 219. Aurobindo Pharma Recent Developments/Updates
 Table 220. Shanghai Bolinger Ingelheim Pharmaceutical Company Information
 Table 221. Shanghai Bolinger Ingelheim Pharmaceutical Description and Business Overview
 Table 222. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 223. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product
 Table 224. Shanghai Bolinger Ingelheim Pharmaceutical Recent Developments/Updates
 Table 225. Shanghai Zhaohui Pharmaceutical Company Information
 Table 226. Shanghai Zhaohui Pharmaceutical Description and Business Overview
 Table 227. Shanghai Zhaohui Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 228. Shanghai Zhaohui Pharmaceutical Meloxicam Product
 Table 229. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
 Table 230. Sichuan Shenghe Pharmaceutical Company Information
 Table 231. Sichuan Shenghe Pharmaceutical Description and Business Overview
 Table 232. Sichuan Shenghe Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 233. Sichuan Shenghe Pharmaceutical Meloxicam Product
 Table 234. Sichuan Shenghe Pharmaceutical Recent Developments/Updates
 Table 235. Ningxia Kangya Pharmaceutical Company Information
 Table 236. Ningxia Kangya Pharmaceutical Description and Business Overview
 Table 237. Ningxia Kangya Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 238. Ningxia Kangya Pharmaceutical Meloxicam Product
 Table 239. Ningxia Kangya Pharmaceutical Recent Developments/Updates
 Table 240. Yangtze Pharmaceutical Group Company Information
 Table 241. Yangtze Pharmaceutical Group Description and Business Overview
 Table 242. Yangtze Pharmaceutical Group Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 243. Yangtze Pharmaceutical Group Meloxicam Product
 Table 244. Yangtze Pharmaceutical Group Recent Developments/Updates
 Table 245. Kunshan Longdeng Ruidi Pharmaceutical Company Information
 Table 246. Kunshan Longdeng Ruidi Pharmaceutical Description and Business Overview
 Table 247. Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 248. Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Product
 Table 249. Kunshan Longdeng Ruidi Pharmaceutical Recent Developments/Updates
 Table 250. Jiangsu Yabang Epson Pharmaceutical Company Information
 Table 251. Jiangsu Yabang Epson Pharmaceutical Description and Business Overview
 Table 252. Jiangsu Yabang Epson Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 253. Jiangsu Yabang Epson Pharmaceutical Meloxicam Product
 Table 254. Jiangsu Yabang Epson Pharmaceutical Recent Developments/Updates
 Table 255. Jiangsu Feima Pharmaceutical Co. , Ltd Company Information
 Table 256. Jiangsu Feima Pharmaceutical Co. , Ltd Description and Business Overview
 Table 257. Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 258. Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Product
 Table 259. Jiangsu Feima Pharmaceutical Co. , Ltd Recent Developments/Updates
 Table 260. Zhejiang Xianju Pharmaceutical Company Information
 Table 261. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 262. Zhejiang Xianju Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 263. Zhejiang Xianju Pharmaceutical Meloxicam Product
 Table 264. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 265. Hainan All Star Pharmaceutical Company Information
 Table 266. Hainan All Star Pharmaceutical Description and Business Overview
 Table 267. Hainan All Star Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 268. Hainan All Star Pharmaceutical Meloxicam Product
 Table 269. Hainan All Star Pharmaceutical Recent Developments/Updates
 Table 270. Key Raw Materials Lists
 Table 271. Raw Materials Key Suppliers Lists
 Table 272. Meloxicam Distributors List
 Table 273. Meloxicam Customers List
 Table 274. Meloxicam Market Trends
 Table 275. Meloxicam Market Drivers
 Table 276. Meloxicam Market Challenges
 Table 277. Meloxicam Market Restraints
 Table 278. Research Programs/Design for This Report
 Table 279. Key Data Information from Secondary Sources
 Table 280. Key Data Information from Primary Sources
 Table 281. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meloxicam
 Figure 2. Global Meloxicam Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Meloxicam Market Share by Type: 2024 & 2031
 Figure 4. by Ingredient Product Picture
 Figure 5. by Route Product Picture
 Figure 6. by Dosage Form Product Picture
 Figure 7. Global Meloxicam Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Meloxicam Market Share by Application: 2024 & 2031
 Figure 9. Rheumatoid Arthritis
 Figure 10. Osteoarthritis
 Figure 11. Soft Tissue Inflammation
 Figure 12. Traumatic Pain
 Figure 13. Post-Operative Pain
 Figure 14. Other
 Figure 15. Global Meloxicam Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Meloxicam Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Meloxicam Sales (2020-2031) & (KG)
 Figure 18. Global Meloxicam Average Price (US$/G) & (2020-2031)
 Figure 19. Meloxicam Report Years Considered
 Figure 20. Meloxicam Sales Share by Manufacturers in 2024
 Figure 21. Global Meloxicam Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Meloxicam Players: Market Share by Revenue in Meloxicam in 2024
 Figure 23. Meloxicam Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Meloxicam Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Meloxicam Sales Market Share by Country (2020-2031)
 Figure 26. North America Meloxicam Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Meloxicam Sales Market Share by Country (2020-2031)
 Figure 30. Europe Meloxicam Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Meloxicam Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Meloxicam Revenue Market Share by Region (2020-2031)
 Figure 38. China Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Meloxicam Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Meloxicam Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Meloxicam Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Meloxicam Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Meloxicam Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Meloxicam by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Meloxicam by Type (2020-2031)
 Figure 60. Global Meloxicam Price (US$/G) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Meloxicam by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Meloxicam by Application (2020-2031)
 Figure 63. Global Meloxicam Price (US$/G) by Application (2020-2031)
 Figure 64. Meloxicam Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools